Clinical Trial Update: Israeli 10 mL Bronchoscopic Lung Volume Reduction (BLVR) Phase 1/2 Emphysema Study - Initial Formulation [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial of an initial bronchoscopic lung volume reduction formulation for pulmonary emphysema was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Emphysema

Snippet

Sponsor: Aeris Therapeutics | Conditions: Pulmonary Emphysema | Phase 1, Phase 2 | Status: TERMINATED